These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 34769106)

  • 1. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease.
    Czapski GA; Strosznajder JB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc utilization by microglia in Alzheimer's disease.
    Shippy DC; Oliai SF; Ulland TK
    J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter-stimulated neuron-derived sEVs have opposite effects on amyloid β-induced neuronal damage.
    Dou Y; Xie J; Tan Y; Zhang M; Zhao Y; Liu X
    J Nanobiotechnology; 2021 Oct; 19(1):324. PubMed ID: 34654438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
    Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H
    J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease.
    Ambrad Giovannetti E; Fuhrmann M
    Brain Res; 2019 Mar; 1707():216-226. PubMed ID: 30503351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
    Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M
    J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
    Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
    Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.
    Kim E; Otgontenger U; Jamsranjav A; Kim SS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glia: A major player in glutamate-GABA dysregulation-mediated neurodegeneration.
    Sood A; Preeti K; Fernandes V; Khatri DK; Singh SB
    J Neurosci Res; 2021 Dec; 99(12):3148-3189. PubMed ID: 34748682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How neurons die in Alzheimer's disease: Implications for neuroinflammation.
    Mangalmurti A; Lukens JR
    Curr Opin Neurobiol; 2022 Aug; 75():102575. PubMed ID: 35691251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
    Cai Y; Liu J; Wang B; Sun M; Yang H
    Front Immunol; 2022; 13():856376. PubMed ID: 35558075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer's disease.
    Abbas G; Mahmood W; Kabir N
    Rev Neurosci; 2016 Jun; 27(4):449-55. PubMed ID: 26812781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia sense neuronal activity via GABA in the early postnatal hippocampus.
    Logiacco F; Xia P; Georgiev SV; Franconi C; Chang YJ; Ugursu B; Sporbert A; Kühn R; Kettenmann H; Semtner M
    Cell Rep; 2021 Dec; 37(13):110128. PubMed ID: 34965412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.
    Floden AM; Li S; Combs CK
    J Neurosci; 2005 Mar; 25(10):2566-75. PubMed ID: 15758166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease.
    Islam R; Choudhary H; Rajan R; Vrionis F; Hanafy KA
    J Cell Physiol; 2024 Jun; 239(6):e30829. PubMed ID: 35822939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention.
    Merlo S; Spampinato SF; Caruso GI; Sortino MA
    Curr Neuropharmacol; 2020; 18(5):446-455. PubMed ID: 32003695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.
    Bhaskar K; Maphis N; Xu G; Varvel NH; Kokiko-Cochran ON; Weick JP; Staugaitis SM; Cardona A; Ransohoff RM; Herrup K; Lamb BT
    Neurobiol Dis; 2014 Feb; 62():273-85. PubMed ID: 24141019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.